The Study of the Decade Results are In!


The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) Study, funded by the CDC, has found that using a combination of chemicals and UVC light to clean patient rooms cut transmission of four major superbugs by a cumulative 30 percent among patients admitted to the same room.


Tru-D’s patented method of measuring reflective dose proven to reduce the risk of infections

Enhanced terminal room disinfection strategies that utilized Tru-D SmartUVC reduced the risk of acquisition and infection caused by target multi-drug resistant organisms by 10 to 30 percent (Sexton, et al, 2015).

These reduction rates, validated through the first and only randomized clinical trial of its kind, differentiate Tru-D from all other devices on the market.

Read the Abstract

The BETR-D Abstract Presented

The long awaited BETR-D abstract, Benefits of Enhanced Terminal Room Disinfection and a Duke Medicine news article have been released.



See the Latest from Duke